KUALA LUMPUR: Hong Seng Consolidated Bhd's (HSC) wholly-owned subsidiary HS Bio Sdn Bhd (HS Bio) has entered into an agreement with LiGNO Holding Sdn Bhd (LHSB) to market and distribute the latter's nutritional supplement product in Malaysia.
The product is a one-of-a-kind supplement that has been scientifically proven to aid in the development of resistance to lung-related and other health issues, including, but not limited to, the Covid-19 virus.
HS Bio is a full-service integrator of pharmaceutical, medical, and healthcare supplies and products, as well as healthcare-related services and supply management for the healthcare industry.
Meanwhile, LHSB is a research and development (R&D) company that has many proprietary knowledge and technology, such as cultivating rare medicinal herbs, extracting their medicinal properties, multiplying these properties, and manufacturing supplements.
As a bionexus company, its cultivation and production facilities are certified and licenced, including ISO22000, HACCP, GMP, Halal, and Organic Certified, and its products have undergone extensive research with research partners from around the world.
Where applicable, LHSB's products are properly certified by the relevant governing bodies, such as the National Pharmaceutical Regulatory Agency (NPRA).
The Malaysia Book of Records has also certified LHSB as the world's first Tiger Milk Mushroom (TMM) cultivation expert.
TMM is a rare occurrence in the wild and is regarded as a national treasure because it has been used in traditional medicine by indigenous populations in Southeast Asia for over 500 years.
History has also documented its use by our local population and foreign traders since colonial times.